Saleem Kamili

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Laboratory diagnostics for hepatitis C virus infection
    Saleem Kamili
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Clin Infect Dis 55:S43-8. 2012
  2. ncbi DNA vaccination against hepatitis E virus infection in cynomolgus macaques
    Saleem Kamili
    Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Gastroenterol Hepatol 17:S365-9. 2002
  3. ncbi Toward the development of a hepatitis E vaccine
    Saleem Kamili
    Centers for Disease Control and Prevention, National Center for HIV Hepatitis STD TB Prevention, Division of Viral Hepatitis, Atlanta, GA 30333, USA
    Virus Res 161:93-100. 2011
  4. ncbi Infectivity of hepatitis C virus in plasma after drying and storing at room temperature
    Saleem Kamili
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
    Infect Control Hosp Epidemiol 28:519-24. 2007
  5. ncbi Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants
    Saleem Kamili
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Antivir Ther 15:477-85. 2010
  6. ncbi Hepatitis E epidemic, Uganda
    Eyasu H Teshale
    Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G37, Atlanta, GA 30333, USA
    Emerg Infect Dis 16:126-9. 2010
  7. ncbi Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis
    Christopher M Howard
    Division of Global Disease Detection and Emergency Response, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Am J Trop Med Hyg 83:1170-3. 2010
  8. ncbi Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection
    Saleem Kamili
    Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30084, USA
    J Infect Dis 189:258-64. 2004
  9. ncbi Suppression of interferon-α signaling by hepatitis E virus
    Chen Dong
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Hepatology 55:1324-32. 2012
  10. ncbi Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012
    Jan Drobeniuc
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Emerg Infect Dis 19:218-22; quiz 353. 2013

Collaborators

Detail Information

Publications23

  1. ncbi Laboratory diagnostics for hepatitis C virus infection
    Saleem Kamili
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Clin Infect Dis 55:S43-8. 2012
    ..The diagnosis of acute HCV infection without the demonstration of seroconversion remains elusive...
  2. ncbi DNA vaccination against hepatitis E virus infection in cynomolgus macaques
    Saleem Kamili
    Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Gastroenterol Hepatol 17:S365-9. 2002
    ....
  3. ncbi Toward the development of a hepatitis E vaccine
    Saleem Kamili
    Centers for Disease Control and Prevention, National Center for HIV Hepatitis STD TB Prevention, Division of Viral Hepatitis, Atlanta, GA 30333, USA
    Virus Res 161:93-100. 2011
    ..However, at this time no approved vaccine against hepatitis E is commercially available...
  4. ncbi Infectivity of hepatitis C virus in plasma after drying and storing at room temperature
    Saleem Kamili
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, 30333, USA
    Infect Control Hosp Epidemiol 28:519-24. 2007
    ..To determine effect of environmental exposure on the survival and infectivity of hepatitis C virus (HCV)...
  5. ncbi Infectivity and vaccination efficacy studies in animal models of HBV S and pol gene mutants
    Saleem Kamili
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Antivir Ther 15:477-85. 2010
    ..Additional hepatitis B vaccine efficacy studies conducted in chimpanzees showed lack of sterilizing immunity against the pol mutant. Whether such mutants can transmit to and infect vaccinated humans requires further investigation...
  6. ncbi Hepatitis E epidemic, Uganda
    Eyasu H Teshale
    Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G37, Atlanta, GA 30333, USA
    Emerg Infect Dis 16:126-9. 2010
    ..This outbreak has progressed to become one of the largest hepatitis E outbreaks in the world. By June 2009, the epidemic had caused illness in >10,196 persons and 160 deaths...
  7. ncbi Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis
    Christopher M Howard
    Division of Global Disease Detection and Emergency Response, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Am J Trop Med Hyg 83:1170-3. 2010
    ..The epidemiologic and environmental water-testing results suggest that household-level factors played an important role in the transmission of HEV-modalities that have been previously underappreciated...
  8. ncbi Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection
    Saleem Kamili
    Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30084, USA
    J Infect Dis 189:258-64. 2004
    ..These results indicate that DNA vaccine with HEV ORF2 administered by gene gun is protective against a heterologous viral challenge...
  9. ncbi Suppression of interferon-α signaling by hepatitis E virus
    Chen Dong
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Hepatology 55:1324-32. 2012
    ..CONCLUSION: HEV inhibits IFN-α signaling through the regulation of STAT1 phosphorylation in A549 cells. These findings have implications for the development of new strategies against hepatitis E...
  10. ncbi Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012
    Jan Drobeniuc
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Emerg Infect Dis 19:218-22; quiz 353. 2013
    ..0). HEV genotype 3 was characterized from 8 nontravelers and genotypes 1 or 4 from 4 travelers. Clinicians should consider HEV infection in the differential diagnosis of hepatitis, regardless of patient travel history...
  11. ncbi Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model
    Saleem Kamili
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Hepatology 49:1483-91. 2009
    ..In the absence of a protective humoral immunity, adaptive cellular immune responses elicited by infection may limit HBV replication and persistence...
  12. ncbi Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances
    Jan Drobeniuc
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 51:e24-7. 2010
    ..Diagnostic sensitivities and specificities as well as interassay agreement varied widely. Analytical sensitivity limits also were determined and were found to be particularly disparate...
  13. ncbi Serological diagnostics of hepatitis E virus infection
    Yury Khudyakov
    Centers for Disease Control and Prevention, National Center for HIV Hepatitis STD TB Prevention, Division of Viral Hepatitis, Atlanta, GA 30333, USA
    Virus Res 161:84-92. 2011
    ....
  14. ncbi Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus
    Bryce D Smith
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 204:825-31. 2011
    ..Although therapies are available that can suppress or eliminate infection, identifying persons infected with HCV is challenging. Rapid tests could help identify many of these persons more expeditiously...
  15. ncbi Rapid diagnostic HCV antibody assays
    Bryce D Smith
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Antivir Ther 17:1409-13. 2012
    ..9-99.3%) and specificity (80-100%) varied. Future investigations could include evaluation of rapid anti-HCV tests in persons who are coinfected with HCV and HIV, and development of rapid HCV-antigen tests and nucleic acid tests...
  16. ncbi Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and nonstructural proteins
    Aufra C Araujo
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS A 33, Atlanta, GA 30333, USA
    J Clin Microbiol 49:54-7. 2011
    ..8% for the acute group and 97.2% for the chronic group. The immunoassay described has the potential to distinguish acute from chronic HCV infection...
  17. ncbi Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up
    Umid M Sharapov
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Hepatology 56:516-22. 2012
    ..CONCLUSION: The seropositivity induced by hepatitis A vaccine given to children <2 years of age persists for at least 10 years regardless of presence of maternal anti-HAV...
  18. ncbi Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda
    Eyasu H Teshale
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Atlanta, Georgia 301333, USA
    Clin Infect Dis 50:1006-10. 2010
    ..Outbreaks of infection with hepatitis E virus (HEV) are frequently attributed to contaminated drinking water, even if direct evidence for this is lacking...
  19. ncbi Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States
    Chen Dong
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 49:4164-72. 2011
    ..HEV infected farmed swine primarily, and the role of other animals as reservoirs of its zoonotic spread appears to be limited...
  20. ncbi Acute hepatitis associated with autochthonous hepatitis E virus infection--San Antonio, Texas, 2009
    Rania A Tohme
    Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:793-6. 2011
    ..Hepatitis E virus genotype 3a related to US-2 and swine hepatitis E virus strains was isolated from one of the patients, indicating potential food-borne or zoonotic transmission...
  21. ncbi Persistence of long-term immunity to hepatitis B among adolescents immunized at birth
    Sandra S Chaves
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 30:1644-9. 2012
    ..Future vaccine recommendations should be based on studies ascertaining protection against clinically significant disease...
  22. ncbi Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area
    Mohammad Sultan Khuroo
    Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    J Gastroenterol Hepatol 19:778-84. 2004
    ..CONCLUSION: Frequent transmission of HEV by blood transfusion places recipients at risk and warrants redefining of the donor screening policy by blood banks, especially in endemic areas...
  23. ncbi Immunity to hepatitis E virus: new insights and future challenges
    Saleem Kamili
    Indian J Gastroenterol 21:136-8. 2002